BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 31350538)

  • 1. Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease.
    Li P; Ge J; Li H
    Nat Rev Cardiol; 2020 Feb; 17(2):96-115. PubMed ID: 31350538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-scale analysis of regulatory protein acetylation enzymes from photosynthetic eukaryotes.
    Uhrig RG; Schläpfer P; Mehta D; Hirsch-Hoffmann M; Gruissem W
    BMC Genomics; 2017 Jul; 18(1):514. PubMed ID: 28679357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of histone deacetylases in embryonic development.
    Dsilva P; Pai P; Shetty MG; Babitha KS
    Mol Reprod Dev; 2023 Jan; 90(1):14-26. PubMed ID: 36534913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-acetylation and its enzymes: overview and new developments.
    Aka JA; Kim GW; Yang XJ
    Handb Exp Pharmacol; 2011; 206():1-12. PubMed ID: 21879443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology and therapeutic implications of HDACs in the heart.
    McKinsey TA
    Handb Exp Pharmacol; 2011; 206():57-78. PubMed ID: 21879446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.
    Schuetze KB; McKinsey TA; Long CS
    J Mol Cell Cardiol; 2014 May; 70():100-7. PubMed ID: 24631770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease.
    Wright LH; Menick DR
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H199-206. PubMed ID: 27208161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.
    Eom GH; Kook H
    Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine acetylation in obesity, diabetes and metabolic disease.
    Iyer A; Fairlie DP; Brown L
    Immunol Cell Biol; 2012 Jan; 90(1):39-46. PubMed ID: 22083525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.
    Van Dyke MW
    ChemMedChem; 2014 Mar; 9(3):511-22. PubMed ID: 24449617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
    Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
    J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assays to Study Enzymatic and Non-Enzymatic Protein Lysine Acetylation In Vitro.
    Graf LG; Vogt R; Blasl AT; Qin C; Schulze S; Zühlke D; Sievers S; Lammers M
    Curr Protoc; 2021 Nov; 1(11):e277. PubMed ID: 34748287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.
    Seok YM; Lee HA; Park KM; Hwangbo MH; Kim IK
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):799-808. PubMed ID: 27106211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson's Disease.
    Wang R; Sun H; Wang G; Ren H
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation in cardiovascular diseases: Molecular mechanisms and clinical implications.
    Yang M; Zhang Y; Ren J
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165836. PubMed ID: 32413386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseases.
    Wang Y; Miao X; Liu Y; Li F; Liu Q; Sun J; Cai L
    Oxid Med Cell Longev; 2014; 2014():641979. PubMed ID: 24693336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics.
    Ali I; Conrad RJ; Verdin E; Ott M
    Chem Rev; 2018 Feb; 118(3):1216-1252. PubMed ID: 29405707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.
    Patrick NM; Griggs CA; Icenogle AL; Gilpatrick MM; Kadiyala V; Jaime-Frias R; Smith CL
    J Steroid Biochem Mol Biol; 2017 Mar; 167():1-13. PubMed ID: 27645313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases.
    Dekker FJ; van den Bosch T; Martin NI
    Drug Discov Today; 2014 May; 19(5):654-60. PubMed ID: 24269836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of protein acetylation influences the redox homeostasis to protect the heart.
    Zúñiga-Muñoz A; García-Niño WR; Carbó R; Navarrete-López LÁ; Buelna-Chontal M
    Life Sci; 2021 Jul; 277():119599. PubMed ID: 33989666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.